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migration
Myriam A Attar and Lorraine C Santy*Abstract
Background: The transition of epithelial cells from their normal non-motile state to a motile one requires the
coordinated action of a number of small GTPases. We have previously shown that epithelial cell migration is
stimulated by the coordinated activation of Arf and Rac GTPases. This crosstalk depends upon the assembly of a
multi-protein complex that contains the Arf-activating protein cytohesin 2/ARNO and the Rac activating protein
Dock180. Two scaffolding proteins that bind directly to cytohesin 2 organize this complex.
Results: We now have found that Rac activation in response to hepatocyte growth factor (HGF) requires cytohesin
2 and Dock180. GRASP/Tamalin is one of the scaffolds that builds the complex containing cytohesin 2 and
Dock180. We determine here that the Ala/Pro rich region of GRASP directly interacts with the SH3 domain of
Dock180. By binding to both cytohesin 2/ARNO and Dock180, GRASP bridges the guanine nucleotide exchange
factors (GEFs) that activate Arf and Rac, thereby promoting Arf-to-Rac signaling. Furthermore, we find that
knockdown of GRASP impairs hepatocyte growth factor (HGF)-stimulated Rac activation and HGF-stimulated
epithelial migration.
Conclusions: GRASP binds directly both cytohesin 2 and Dock180 to coordinate their activities, and by doing so
promotes crosstalk between Arf and Rac.
Keywords: Cytohesin, GRASP, Tamalin, Dock180, Arf6 and Rac1Background
Epithelial cells form barriers that can selectively regulate
transport between different compartments. An extensive
network of junctions joins the cells into sheets and
limits their mobility under normal circumstances. How-
ever these cells do become migratory under both normal
and pathological conditions. Epithelial cells must mi-
grate during normal development and during the repair
of damage. In addition cancerous epithelial cells aber-
rantly activate pro-migratory pathways during metasta-
sis. Epithelial migration involves a remodeling of the
cell’s structure and behavior that starts by redirecting
polarity in the direction of migration. At the leading* Correspondence: lcsanty@psu.edu
Department of Biochemistry and Molecular Biology, The Pennsylvania State
University, 208 Althouse Lab, University Park, PA16802, USA
© 2013 Attar and Santy; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the oredge, actin rich protrusions and new cell-matrix adhe-
sions anchor the cell to help propel the cell forward and
the trailing edge retracts [1]. Epithelial cells can adopt
several different types of migration depending on the
biological circumstances at hand [2]. During tissue mor-
phogenesis, development and wound healing, epithelial
cells move in sheets. In this case, they maintain their
cell-cell junctions [3]. Epithelial cells can also detach
from each other and migrate individually during devel-
opment or cancer metastasis [4].
Epithelial cell motility is initiated by various growth
factors, such as HGF, EGF, PDGF, VEGF, CSF-1, FGF
and TGF-β [5-10]. HGF, also known as Scatter Factor
(SF), is a potent motogen for numerous epithelial cells
expressing the c-Met receptor [11]. It induces scattering
of multiple epithelial cell lines in 2D culture [12-14].ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.biomedcentral.com/1471-2121/14/9When epithelial cells are grown in 3D cultures, addition of
HGF to the growth media initiates tubulogenesis [14,15].
HGF production by mesenchymal cells [16] is increased in
the event of injury to epithelia [17]. In addition, HGF is in-
volved in the invasive behaviors of some cancers [18].
A number small GTPases, including members of the
Ras, Rho and Arf families regulate the cell shape changes
that underlie motility. There are six Arf proteins, and
Arf6 in particular has been implicated in the regulation
of cell shape and motility. Initially, Arf6 was shown to
regulate intracellular trafficking processes like endocyto-
sis and recycling of membrane proteins [19,20]. But it
has subsequently been shown that Arf6 is also involved in
regulating the actin cytoskeleton during migration and
phagocytosis [21-26]. Arf6 is required for HGF stimulated
epithelial cell motility [23]. HGF will induce MDCK cells in
culture to scatter from islands and increased Arf6 acti-
vation is observed as soon as 1 hour post HGF treatment
[23,26-28]. More recently, we found that CNK3/IPCEF, a
scaffold that binds the Arf-activating cytohesin proteins, is
necessary for the activation of Arf6 downstream of HGF
and for HGF-stimulated migration [29].
While there are 6 Arf proteins in mammalian cells, a
much larger number of proteins have been identified as
Arf activating guanosine exchange factors (GEFs). There
are 15 identified sec7 Arf GEFs divided into 5 subfam-
ilies. It is thought that the various Arf-GEFs activate Arfs
at different subcellular locations and in response to dif-
ferent signals. One class of Arf-GEFs, the cytohesins, has
been extensively implicated in the regulation of cell shape
and migration. There are 4 cytohesins. Cytohesin1 and 4
are mostly hematopoetic whereas cytohesin 2/ARNO and
cytohesin 3/Grp-1 are ubiquitously expressed [30].
Overexpression of cytohesin 2/ARNO enhances cell
motility in MDCK cells [26], and the phenotype is strik-
ingly reminiscent of the response of these cells to HGF.
Cytohesin 2-induced scattering of MDCK cells requires
the activation of Rac1 by the Rac-GEF, Dock180 [31].
Cytohesin 2-dependent Rac activation also depends on the
coiled-coil domain in cytohesin 2 [32]. We previously found
that cytohesin 2 and Dock180 associate within a larger
complex and can be co-immunoprecipitated. IPCEF/CNK3
and GRASP, two scaffold proteins that both bind the
coiled-coil domain of cytohesin 2, are necessary for the as-
sembly of this complex, and for cytohesin dependent Rac
activation [32]. These data led us to propose a model where
one scaffold recruits cytohesin 2 to the membrane in re-
sponse to upstream signals, while the other acts as a bridge
linking cytohesin 2 and Dock180. Our demonstration that
CNK3/IPCEF is required for activation of Arf6 by HGF
suggests that it is the scaffold that recruits cytohesin 2 in
response to upstream signals.
Here, we test the hypothesis that GRASP binds to both
Dock180 and cytohesin 2 and bridges the two GEFs. Wefind that GRASP interacts with Dock180 independently
of its ability to bind cytohesin 2. Dock180 and GRASP
interact via the SH3 domain of Dock180 and the proline
rich domain of GRASP. Furthermore, in addition to
physically bridging cytohesin 2 and Dock180, GRASP af-
fects cell migration directly. Knockdown of GRASP in-
hibits HGF-induced migration in MDCK cells.
Results
HGF-induced cell migration and Rac activation are
mediated by cytohesins and Dock180
Our previous work has shown that cytohesin 2 can pro-
mote epithelial migration by stimulating the activation
of Arf6 and the subsequent activation of Rac1 [26,31].
Cytohesin 2 induces Rac activation by associating with
the Rac-GEF Dock180. This interaction is mediated by
the scaffolding proteins CNK3 and GRASP, and knock-
down of GRASP or CNK3 inhibits cytohesin 2-induced
Rac activation [32]. We have also found that knockdown
of CNK3 inhibits HGF-stimulated Arf6 activation and
migration [29]. These data suggest that the cytohesin-
dependent Arf-to-Rac signaling module may act during
HGF-stimulated motility. In order to test this hypothesis
we tested the effect of inhibition of cytohesins and
Dock180 on HGF-stimulated Rac activation. We incu-
bated MDCK cells with HGF for six hours and added
SecinH3, a specific, small-molecule cytohesin inhibitor,
or adenovirus encoding a catalytically inactive and dom-
inant negative Dock180 mutant (DockISP) to selected
samples. We then evaluated the effect of inhibiting ei-
ther GEF on Rac activation using a GST-PBD pulldown
assay. When the GEF activity of either cytohesins or
Dock180 was impaired, Rac activation by HGF was sig-
nificantly impaired (Figure 1A and 1B). To further con-
firm that HGF-induced migration is dependent on the
GEF activities of cytohesins and Dock180, we evaluated
wound healing in the presence of SecinH3 and DockISP.
MDCK cells were grown to form a monolayer around
plugs in the Platypus migration chambers. The plugs were
removed and the cells were allowed to migrate into the
wound in the presence or absence of 1ng/ml of HGF. The
suppression of cytohesin or Dock180 activity reduced the
amount of wound filled in HGF-stimulated samples, but
had no significant effect on basal migration (Figure 1C
and 1D). Both results are consistent with the conclusion
that cytohesin dependent Arf-to-Rac signaling promotes
epithelial cell migration downstream of HGF.
The scaffolding protein GRASP binds independently to
both cytohesin 2/ARNO and Dock180
We know that cytohesin dependent Arf-to-Rac activation
depends on the assembly of cytohesins and Dock180 and
scaffolding proteins into a multiprotein complex [32]. We
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Figure 1 Inhibition of cytohesin or Dock180 activity impairs HGF-stimulated Rac activation and wound healing. A,B) HGF-dependent Rac
activation is impaired by SecinH3 or dominant negative Dock180. MDCK cells were incubated in the presence or absence of 20 ng/ml HGF for 6
hrs. SecinH3 (15 μM), a specific cytohesin inhibitor or adenovirus encoding the dominant negative Dock180 mutant, DockISP, were added as
indicated. Rac-GTP was isolated by pulldown with GST-PBD. Pulldown samples and saved aliquots of the starting lysates were Western blotted
with antibodies to Rac and Dock180. Four independent experiments were quantitated by densitometry (A) ** = p < 0.01, paired T test. Gels from
one of these experiments are shown (B). C,D) SecinH3 and DockISP inhibit HGF-stimulated wound healing. MDCK cells were plated in 96 well
Oris migration chambers (Platypus technologies) around plugs. 24 hours later the plugs were removed to create a wound. Wounded monolayers were
incubated in the presence or absence of 1 ng/ml HGF with the addition of 30 μM SecinH3 or adenovirus encoding DockISP as indicated for 18 hours.
Cells were then fixed and stained with crystal violet. The area of the remaining wound was measured using ImageJ. C) The extent of wound healing in
multiple replicate samples from multiple independent experiments was quantitated: Control (n = 67 wells from 12 experiments); SecinH3 (n = 37 wells
from 10 experiments); DockISP (n = 24 wells from 4 experiments). Data shown are mean ± standard error. ** = p < 0.01, T test. D) Representative images
of the starting wound and wounds after 18 hours of migration in the presence or absence of HGF Bar = 500 μM.
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ordinates the association of Dock180 with cytohesin 2/
ARNO. We have found that CNK3 plays a crucial role in
initiating Arf activation downstream of HGF [29].
GRASP on the other hand, seemed to be a good candi-
date for bridging Dock180 and cytohesin 2. GRASP, also
known as Tamalin, consists of multiple protein-protein
interaction domains (Figure 2A), and binds to cytohesin
2/ARNO via its leucine rich region [33-35]. If GRASP
acts to links together cytohesin-2 and Dock180, then it
should bind directly to both GEFs. GRASP binds to
cytohesins via the direct interaction of its leucine rich
domain with the cytohesin coiled-coil domain [33]. We
have previously shown that Dock180 and GRASP can be
co-immunoprecipitated when co-expressed in MDCK
cells [32]. Therefore, we produced a series of truncations of
GRASP (Figure 2A) in order to narrow down the domain
that interacts with Dock180 and to test if GRASP caninteract with Dock180 independently of cytohesin 2/ARNO.
Cells expressing wild type flag-tagged Dock180 and the vari-
ous truncations of HA-tagged GRASP were lysed and the
post-nuclear supernatant was subjected to immunoprecipi-
tation (as described in Experimental Methods). Dock180
co-immunoprecipitated with GRASP regardless of the pres-
ence or absence of its cytohesin-binding domain (Figure 2B).
By interacting with both Dock180 and cytohesins via separ-
ate domains, GRASP can act as a bridge to co-localize the
GEFs for Arf6 and Rac1.
The SH3 domain of Dock180 and the alanine/proline rich
region of GRASP mediate the direct interaction between
the two proteins
We previously demonstrated that the N-terminal 357
amino acids of Dock180 were responsible for the interaction
with cytohesin 2/ARNO [32]. Furthermore knockdown of
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Figure 2 GRASP co-IPs with Dock180 independently of its
cytohesin binding activity. A) GRASP truncation constructs used in
these experiments. All constructs are myc-tagged at the N-terminus.
B) Hek 293 cells were co-transfected with the indicated GRASP
constructs and Dock180. Cells were then lysed, and Dock180
immunoprecipitated with M2-flag resin. The immunoprecipitates were
blotted with mouse anti-myc and goat anti-Dock180 antibodies.
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tion. If GRASP is linking cytohesin 2/ARNO to Dock180
then this same region should be required for the interaction
of GRASP and Dock180. We found that the N-terminus of
Dock180 does indeed mediate the interaction with GRASP
(Figure 3A) supporting the hypothesis that GRASP is bridg-
ing Dock180 and cytohesin 2/ARNO. Furthermore, we fur-
ther refined our localization of the region of Dock180 that
interacts with GRASP by producing a truncation of the first
80 amino acids of Dock180. This portion of Dock180
encodes a SH3 domain. This Dock180 truncation or full-
length Dock180 were transfected along with HA-tagged
wild type GRASP into HEK 293 cells. The ability of the
Dock180 truncation to interact with GRASP was tested by
co-immunoprecipitation. WT GRASP fails to interact with
the truncation of Dock180 that lacks the SH3 domain. Simi-
larly we further defined the region of GRASP required for
this interaction by producing a truncation of GRASP lack-
ing the N-terminal 82 amino acids, which includes the
proline-rich domain. Del82-GRASP did not interact with
Dock180 (Figure 3B). Therefore we conclude that the SH3
domain of Dock180 preferentially binds to the proline-rich
region of GRASP.
However since these proteins were immunoprecipitated
out of cell lysates the interaction could be indirect. In order
to determine if the interaction between Dock180 and
GRASP is direct, we purified full length GRASP fused to
GST and the N-terminal 80 amino acids of Dock180 fused
to a Flag tag from E.coli and allowed them to interact
in vitro. GRASP interacted with the N terminal 80 aminoacids of Dock180 (Figure 3C). This confirms that GRASP
can directly interact with Dock180 as well as with cyto-
hesins and can act as the anchoring scaffolding protein that
bridges cytohesin 2 and Dock180 and promotes therefore
Arf6 to Rac1 activation.
The co-immunoprecipitation experiments demons-
trate that the Dock180 SH3 domain can interact with
GRASP’s proline-rich domain. We wanted to confirm
that these proteins interact within intact cells. The Bi-
Molecular Fluorescent complementation assay, or BiFC
for short, is based on the assembly of the N and C ter-
minal fragments of Venus into a fluorescent protein.
The individual fragments VN and VC are not fluorescent
individually. The detection of fluorescence depends on
in vivo assembly of the fragments into a functional YFP
molecule, which only occurs if they are fused to proteins
that interact [36]. We designed VN-Dock180 and VC-
GRASP and co-transfected them into MDCK cells. Cells
were then fixed and stained as described in Experimental
Methods. GRASP and cytohesin 2/ARNO are known to
interact via the coiled-coil domain of cytohesin 2/ARNO
and the leucine rich region in GRASP [33]. We used the
interaction of VN-cytohesin 2 and VC-GRASP as a posi-
tive control for the detection of YFP (Figure 4 row #1).
VN-Dock180 and VC-GRASP also produce YFP fluores-
cence when co-expressed in MDCK cells (Figure 4 row #2).
VN-Del80-Dock180 fails to produce YFP when co-
expressed with VC-GRASP (Figure 4 row #3), confirming
the co-immunoprecipitation data shown in Figure 3. When
MDCK cells were transfected with a plasmid containing
the truncation of VC-GRASP lacking the first 82 amino
acids of GRASP, and full length VN-Dock180, the two pro-
teins also failed to show interaction by detection of YFP
(Figure 4 row #4). These results confirm that the SH3 do-
main of Dock180, located in the N-terminal 80 amino
acids, and the Ala/Pro rich region of GRASP mediate the
interaction of the two proteins, thus confirming the obser-
vations made in the co-IP studies shown above.
GRASP knockdown inhibits HGF stimulated migration and
Rac activation
Our data suggest that cytohesin 2/ARNO and Dock180
interact indirectly via GRASP and that HGF stimulated
Rac activation and migration require both cytohesins
and Dock180. Therefore, we hypothesized that both
HGF-induced migration and HGF-stimulated Rac activa-
tion would be impaired by knockdown of GRASP.
MDCK cells were transfected with control or GRASP
targeting siRNAs (Figure 5D). The HGF-stimulated and
basal levels of migration of these cells were tested using
both a wound healing assay and a transwell migration
assay (Figure 5A-C). HGF-induced migration, but not
basal migration, is significantly decreased after reducing
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Figure 3 Dock180 directly binds to GRASP. A) Localization of the GRASP-binding domain in Dock180. Hek 293 cells expressing HA-GRASP and
the indicated VN-flag-Dock180 constructs were lysed, and incubated with M2 anti-flag resin as described in Materials and Methods. The
immunoprecipitates as well as saved samples of the starting lysate were blotted with goat anti-Dock180 and mouse anti-HA. B) Localization of
the Dock180-binding domain in GRASP. Hek 293 cells expressing HA-GRASP or a version lacking the ala/pro rich region (del82-GRASP) and flag-
Dock180 constructs were lysed, and incubated with M2 anti-flag resin as described in Experimental Procedures. The immunoprecipitates as well
as saved samples of the starting lysate were blotted with goat anti-Dock180 and mouse anti-HA. C) GRASP directly binds the SH3 domain of
Dock180. E. coli were transformed with pGEX2T-GRASP or pST50Tr-FLAGyGcn5x-Flag-Dock180 (11KDa). The expressed proteins were purified as
described in Materials and Methods. GST-GRASP (70 KDa) was eluted from the Sepharose resin using a solution of Glutathione. It was then added
to either M2-Flag Sepharose gel or M2-Flag-Dock180 beads. The resin was washed three times and attached proteins were eluted in 30μl sample
buffer. GRASP and Dock180 were detected by GelCode (Coomassie) staining and Western blotting with Goat anti-GRASP as well as goat anti-
Dock180 antibodies (N-terminal).
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http://www.biomedcentral.com/1471-2121/14/9reduced migration is due reduced activation of Rac in
response to HGF. We determined the amount of active
Rac in MDCK cells transfected with control or GRASP-
targeting siRNAs in the presence and absence of HGF
stimulation. The GRASP knockdown cells had reducedlevels of HGF-stimulated Rac activation (Figure 5E,F). This
reduced level of Rac activation was not due to impaired
cMet activation in response to HGF. GRASP knockdown
cells had a similar pattern of cMet activation to that seen








































































Figure 4 Dock180 interacts with GRASP in live cells. A split YFP system was used to demonstrate the interaction of Dock180 and GRASP in
cells. Dock180 and GRASP were respectively labeled with the N and C-terminal halves of venus (VN-Dock180 or VC-GRASP). Neither VN nor VC is
fluorescent by itself. YFP fluorescence is reconstituted if the two fusion partners interact, thereby bringing VN and VC into close proximity so that
a functional YFP can be formed. MDCK cells were transfected with the indicated constructs using NeonW (1400, 20, 2). They were then plated on
Fibronectin coated coverslips. After 18 hours, Cells were fixed and stained with mouse anti-myc (cytohesin 2) or mouse anti- Flag (Dock180)
followed by Dylight™ 594- conjugated anti-mouse secondary antibody and rabbit anti-HA (GRASP) followed by Dylight™649- conjugated anti-
rabbit secondary antibody. In the merge cytohesin 2 or Dock180 are psuedocolored red, GRASP is psuedocolored blue, and the YFP channel
detecting Venus indicating that the 2 expressed proteins interact is pseudocolored green. Bar, 10 μm.
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http://www.biomedcentral.com/1471-2121/14/9hour of HGF treatment (Figure 5G). We conclude that the
GRASP mediated association of cytohesins and Dock180 is
required for Rac activation and migration in response to
HGF.
Discussion
In this study we demonstrated that GRASP/Tamalin, in
addition to binding cytohesins, also interacts with Dock180.
We have previously shown that both GRASP and IPCEF/CNK3 are required for the interaction of cytohesin 2/
ARNO and Dock180 and for cytohesin induced Rac activa-
tion. The need for two scaffolding proteins to bring about
this pro-migratory protein complex was surprising. We hy-
pothesized that one scaffold recruits cytohesin 2/ARNO in
response to upstream signals, while the other bridges
cytohesin 2/ARNO and Dock180. Further studies in our
lab showed that the CNK3/IPCEF acts downstream of HGF







Control GRASP siRNA 
0 ng/ml HGF 




















































0 ng/ml HGF 




































0 ng/ml HGF 




















0 1 2 3 4 6 0 1 2 3 4 6
Figure 5 Knockdown of GRASP inhibits HGF induced migration and Rac activation in MDCK cells. A) GRASP levels in MDCK cells were
reduced by transfection of siRNA and cell migration measured using the Oris migration chamber. B) Cell migration was quantitated by measuring
the percent of the starting open area covered. Data shown are the mean ± standard error of at least 15 separate samples. C) GRASP knockdown
and control cells were allowed to migrate in a transwell chamber toward 10 ng/ml HGF. Data shown are the mean ± standard error of at least 15
separate experiments. Migration of the knockdown and control cells in both B. and C was compared using a standard t-test. ** p < 0.01.
D) MDCK cells were transfected with control or GRASP-targeting siRNA as described in Experimental Procedures. After 48 hours mRNA was
isolated and RT-PCR of the canine GRASP or GAPDH performed. E) MDCK cells were transfected with siRNAs and 24 hours later were split onto
duplicate plates. The next day the cells were incubated in the presence or absence of HGF for 5 hours and active Rac isolated by binding to GST-
PBD. Rac levels in saved aliquots of the starting lysates and the isolated Rac-GTP were detected by Western blotting. F) Rac activation levels in 4
independent knockdown experiments were normalized to the level of active Rac in the control 0 ng/ml HGF sample. Rac activation in the HGF
stimulated control and GRASP knockdown samples were compared using a paired t Test. Data shown are mean ± standard error. * = p < 0.05.
G) MDCK cells were transfected with control or GRASP siRNAs. After 48 hours the cells were treated with 20 ng/ml HGF for the indicated times,
harvested and blotted for phosphorylated cMet and total cMet.
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http://www.biomedcentral.com/1471-2121/14/9that GRASP is the scaffolding protein that brings the GEFs
of Arf6 and Rac1 together by binding to both. We have
shown here that GRASP binds directly to Dock180, inde-
pendently of its cytohesin binding domain. These dataprovide evidence to support the model that GRASP acts to
bridge Dock180 and cytohesin 2/ARNO. Truncations of
Dock180 and GRASP allowed us to determine that the
SH3 domain at the N-terminus of Dock180 and the proline
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http://www.biomedcentral.com/1471-2121/14/9rich region at the N-terminus of GRASP are the regions
that interact. Furthermore, knockdown of GRASP im-
pairs HGF-stimulated migration. These studies identify
GRASP as a lynchpin molecule that links cytohesin-
dependent Arf activation to Dock180 dependent Rac ac-
tivation (Figure 6).
In addition to meditating protein-protein interactions,
the SH3 domain present in some Dock180 related pro-
teins also regulates the GEF activity of these proteins. In
fact, the SH3 domain has autoinhibitory properties [37].
A Dock180 mutant that lacks the SH3 domain activates
Rac1.5 fold higher than the wild type Dock180. Inter-
action of this domain with GRASP might have the fur-
ther effect of relieving this auto-inhibition.
Dock-related proteins are atypical GEFs for Rho GTPases.
They differ from the bigger class of Rho GEFs known as
the (DH-PH)-containing family of GEFs [38-40]. There are
11 mammalian Dock-related proteins divided into 4 sub-
families [41]. The DOCK-A and DOCK-B subfamilies con-
tain a SH3 domain at their N-termini that differentiates
them from the DOCK-C and DOCK-D subfamilies. The
presence of a SH3 domain suggests that other members of
the DOCK-A and DOCK-B families may be able to bind
GRASP and coordinate with cytohesin dependent Arf
activation. The members of these sub-families include
Dock180, Dock2 and Dock5 for the A subfamily and Dock3
and 4 for the B subfamily.
Dock2 is present primarily in hematopoetic cells,
whereas Dock180 is absent in these cells. Dock2 plays a
role in lymphocyte development, homing, activation, ad-
hesion, polarization and migration [41-44]. There are
hematopoetic isoforms of cytohesins, namely Cytohesin 1
and Cytohesin 4. Cytohesins can regulate integrin function
and trafficking and therefore migration and adhesion inFigure 6 A comprehensive model for the dual action of GRASP and C
IPCEF play distinct roles in bringing this multiprotein complex together. On
in response to upstream signals (HGF) while the other, GRASP, binds both
complex promotes HGF-stimulated Rac activation and migration.epithelial cells [26,45,46] and in hematopoetic cells
[47,48]. No studies have yet investigated coordination be-
tween hematopoetic Dock-related proteins and cytohesins,
so it remains to be seen if similar mechanisms are at work
in these cells.
Dock3 in conjunction with NEDD9 promotes EMT, mes-
enchymal migration and metastasis of cancer cells [49,50].
Mesenchymal migration is characterized by the activation
of Rac and the production of lamellipodia. This type of
migration is consistent with HGF and cytohesin-induced
motility. Furthermore activation of Arf6 has also been cor-
related with enhanced metastasis [27,51]. Similarly to the
effects of Dock2 on hematopoetic cell migration, it is not
yet known if cytohesins regulate NEDD9/Dock3 stimulated
migration.
Another area where both DOCK-A or DOCK-B pro-
teins and cytohesins have been implicated is the neur-
onal development. Dock3 regulates neurite outgrowth
[52,53], while Dock 4 has been implicated in the regula-
tion of dendritic development [54], Rac-dependent cell
migration [55] and tumorigenesis [56]. Cytohesins have
also been shown to regulate neurite outgrowth and
dendritic branching in hippocampal neuron cultures
[57-59]. All of these functions involve cytohesins and the
SH3-containing DOCK family members, and therefore
might involve coordination by GRASP.Conclusions
The results reported here in conjunction with our earlier
studies allow us to build a detailed model to explain how
cytohesins coordinate with Dock180 to promote Rac activa-
tion and cell migration as shown in Figure 5. We propose
that Arf6 induced Rac1 activation depends on the assemblyNK3/IPCEF in promoting Arf to Rac crosstalk. GRASP and CNK3/
e of the scaffolds, CNK3/IPCEF recruits cytohesin 2 to the membrane
cytohesin 2 and Dock180 providing a physical bridge. Assembly of this
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http://www.biomedcentral.com/1471-2121/14/9of a multiprotein complex containing the GEFs, cytohesin 2
and Dock180/Elmo1, as well as the necessary scaffolding
proteins that bring the complex together and to its proper
location in the cell (Figure 6).
An external stimulus, in this case HGF, activates a cas-
cade of events. This leads to the recruitment of cytohesin
2/ARNO where it’s needed for the activation of Arf6 [29].
The proper functioning of cytohesin 2/ARNO is not only
dependent on its catalytic ability to facilitate the GDP to
GTP exchange on Arfs, but also on its interactions with
scaffolding proteins [32]. We demonstrated that CNK3/
IPCEF is the scaffolding protein necessary for activation of
Arf6 [29]. However, cytohesin 2 also binds another scaffold-
ing protein, GRASP/Tamalin [33]. And as we previously de-
scribed, knockdown of the expression of either CNK3/
IPCEF or GRASP/Tamalin impairs the assembly and func-
tion the multiprotein complex described above and the
ability of cytohesin 2/ARNO to stimulate Rac [32]. The data
shown in this paper defines the role of GRASP as providing
a physical bridge between cytohesin 2 and Dock180, thus is
coordinating the activation of Arf6 and Rac1.
The scaffolding protein GRASP completes the picture
on the large multiprotein complex that brings Arf6 and
Rac1 together. The proline rich region of GRASP binds
the SH3 domain of Dock180, while its leucine rich do-
main binds cytohesin 2. GRASP therefore helps GEFs
co-localize activation of GTPases, and promotes cross-
talk between Arf and Rac.Methods
Antibodies and reagents
The mouse anti-HA (16B12) was purchased from
Covance (Princeton, NJ). Goat anti-Dock180 antibodies
(C-19, N-19) were obtained from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA). The mouse anti-Flag antibody was
obtained from Sigma (St Louis, MO). DyLight™ 649 con-
jugated donkey anti-rabbit as well as DyLight™ 594 conju-
gated donkey anti mouse were purchased from Jackson
ImmunoResearch laboratories (West Grove, PA). Anti
phospho-cMet (Y1234/1235 clone D26) and Anti-cMet
(clone 25H2) were purchased from Cell Sigaling (Danvers,
MA). M2 anti-flag resin was purchased from Sigma (St.
Louis, MO). And CL4B beads were obtained from Fluka
(Germany) and GelCode Blue and glutathione-sepharose
from Thermo Scientific (Rockford, IL). Western blots
were processed by incubation with HRP-labeled secondary
antibodies followed by Millipore Immobilion ECL reagent.
Blots were developed using X-Ray film or with the c-Digit
imaging system (LI-COR Biosciences, Lincoln, NE).Cell lines
Tet-off MDCK cells were obtained from Clontech. 293H
cells were obtained from Invitrogen (Carlsbad, CA). TheT23 line of MDCK II as well as the 293H cells were
maintained in DMEM supplemented with 10% FBS and
penicillin, streptomycin and fungizone. All cells were
maintained at 37°C and 5% CO2. Cell media was pur-
chased from Mediatech (Manassas, VA) and FBS from
Gemini (West Sacramento, CA).
siRNA mediated knockdown
The siRNA targeting human and dog GRASP (target se-
quence: GCTTTGAGATCCAGACTTA) was obtained
from Dharmacon (Lafayette, CO) and BlockItW control
siRNA from Invitrogen (Carlsbad, CA). siRNAs were
transfected into T23 cells using the NeonW system from
Invitrogen (Carlsbad, CA). Transfections were carried
out using the manufacturer’s suggested protocol: (1650
mV, 20 ms, 1 pulse) for MDCK cells.
Migration assay
Control or GRASP-targeting siRNAs were transfected into
the cells using Neon. Cells (7×105) were seeded in the wells
of the Oris migration chambers (Platypus technologies,
Madison, WI) and incubated for 24 hours. Plugs were
removed and media was refreshed before addition of HGF
(1 ng/ml). Cells were allowed to migrate for another 18
hours. Cells were fixed with 4% paraformaldehyde and
stained with a 0.1% solution of crystal violet. Images of the
chambers were taken and cell migration was quantified by
comparing the empty areas in the control versus GRASP
knockdown on Image J. For the transwell migration assay,
GRASP knockdown was performed as outlined above. The
cells were allowed to migrate through the chambers as de-
scribed in Attar et. al., 2012 [29].
Primers
Del82-GRASP forward: 50-CAC GCTCGAGACCATGG
CATACCCATACGATG TCCTGACTATGCAGGCTCA




HEK 293 cells were transfected (calcium phosphate)
with plasmids encoding various forms of Dock180 and
GRASP. They were allowed to express overnight. Cells
were lysed in 50mM Tris, pH 7.5, 150mM NaCl, 10 mM
NaF, 1 mM NaVO4, 10 mM sodium pyrophosphate, 1%
Triton X-100 and 0.1 mM PMSF and 1 mg/ml each
pepstatin, leupeptin, and antipain. Lysates were clarified
with Sepharose CL-4B beads and unclarified materials
removed after 10 minutes at 12,000 × g. Some of the
cleared cell lysate was saved (3% was used for protein
expression) and the remainder was then incubated rotat-
ing overnight 4°C with acid-washed M2-anti Flag resin.
The process involved washing the resin three times with
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and finished with 3 more washes with TBS. IPs were
washed three times with lysis buffer and once with TBS.
Precipitated proteins were eluted into SDS-PAGE sam-
ple buffer and the samples were boiled for 3 minutes
then analyzed by Western blot.
cMet activation
MDCK cells were transfected with siRNAs as described
for migration assays. 48 hours later the cells were treated
with 20 ng/ml HGF for the indicated times and harvested
as described for immunoprecipitations. Unsolubilized ma-
terial was removed by centrifugation and the supernatant
Western blotted with anti-phospho-cMet and anti-cMet
antibodies.
Immunofluorescence
MDCK were plated on fibronectin coated glass coverslips
(40 μg/ml). They were fixed and stained as previously de-
scribed [26]. Cells were observed and photographed using
an Olympus IX81 equipped with SlideBook5 software for
image processing.
RT-PCR
Total RNA was isolated using the RNeasy kit (Qiagen).
Custom primers to amplify bases 153–511 of canine
GRASP, and ReadyMade primers to amplify GAPDH
were obtained from Integrated DNA Technologies. RT-
PCR was performed with 0.5 μg total RNA as template
for GAPDH and 2 μg as template for GRASP using the
Qiagen One-Step RT-PCR kit.
In Vitro binding assay
The coding sequence of GRASP was inserted to the
pGEX2T plasmid to produce an in-frame fusion of GRASP
to GST. This plasmid was transfected into BL21 E. coli.
Cultures were grown to OD600 = 0.4 and then expression
of GST-GRASP was induced by addition of IPTG for 4
hours. Cells were then lysed in PBS + 0.01% Triton X-100
for 10 minutes. The lysate was cleared by centrifugation
and added to Glutathione-Sepharose beads. After rotation
for 2 hours, beads were washed and GST-GRASP was
eluted using a 10 mM solution of glutathione.
The coding sequence of the N-terminal 80 amino acids
of Dock180 was fused in frame to a Flag tag using the
bacterial expression plasmid pST50 [60] and expression
was induced as indicated above. Cells were lysed in 50
mM tris pH 7.5, 20% sucrose and 10% glycerol. The
cleared lysate was added to M2-Flag gel and incubated
rotating for 2 hours then washed with lysis buffer to re-
move unbound proteins.
Eluted GST-GRASP was added to either the Dock180
conjugated M2-Flag resin or to just the M2-Flag gel as a
control. TBS was added and samples were rotated at 4°Cfor 2 hours washed and the proteins were then eluted in
SDS-PAGE sample buffer. Proteins were detected by
GelCode staining and Western blot using the goat anti-
GRASP and the N-term goat anti-Dock180 antibodies.
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